Clinical Trials
3 trialsNCT03088124 2026-03-20
PC-ARN
Institut Paoli-Calmettes
Phase 2 Completed
NCT03740191 2025-05-11
Spot-Scanning Based Hypofractionated Proton Therapy for Low and Intermediate Risk Prostate Cancer
EBG MedAustron GmbH
Phase NA Terminated
NCT03849365 2021-03-23
Study of Erectile Dysfunction, Urinary Incontinence and Related QoL After TOOKAD® VTP for Low Risk Prostate Cancer
Steba Biotech S.A.
Phase 4 Terminated